Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666757 · ClinicalTrials.gov registry record · Phase 4
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 750
- Enrollment target
NCT00666757 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 750 participants.
The verdict
NCT00666757, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 750 participants
- Enrollment target
Study Summary
The purpose of this study is to compare duloxetine with other antidepressants in the treatment of severe depression.
Interventions
- DRUG sertraline
- DRUG duloxetine
- DRUG paroxetine
- DRUG fluoxetine
- DRUG citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00666757
The ClinicalTrials.gov registry entry for NCT00666757 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which sertraline is the first listed.
NCT00666757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00666757 about?
NCT00666757 is a clinical study titled "A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression". The purpose of this study is to compare duloxetine with other antidepressants in the treatment of severe depression.
What is the current status of trial NCT00666757?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 750 participants. The study started on 2008-05. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00666757?
The interventions under investigation include: sertraline (DRUG), duloxetine (DRUG), paroxetine (DRUG), fluoxetine (DRUG), citalopram (DRUG).
Who is sponsoring clinical trial NCT00666757?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.